MDxHealth
Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests
Under the local coverage determination, tests to help identify patients who may benefit from a prostate biopsy would be covered under certain conditions.
In Brief This Week: Unilabs, PerkinElmer, Invitae, Becton Dickinson, and More
News items for the in vitro diagnostics industry for the week of April 19, 2021.
MDxHealth 2020 Revenues Up 57 Percent
Billable test volume for the company's ConfirmMDx and SelectMDx prostate cancer test fell year over year, but rose sequentially from the third quarter.
Oppenheimer Initiates Coverage of MDxHealth at Outperform
The investment bank cited its expectation for a positive coverage decision from Medicare for the company's SelectMDx prostate cancer test, among other reasons.
MDxHealth Q3 2020 Revenues Drop 6 Percent
For the three months ended Sept. 30, the Belgian molecular diagnostic firm's revenues fell to $4.5 million from $4.7 million in Q3 2019.
Feb 26, 2020
MDxHealth 2019 Revenues Fall 58 Percent
Aug 29, 2019
MDxHealth H1 2019 Revenues Fall 37 Percent
Apr 24, 2019
MDxHealth Q1 Revenues Drop 51 Percent
Aug 30, 2018